Platelets, Coagulation, and the Liver

Chesley's Hypertensive Disorders in Pregnancy

Volumn , Issue , 2009, Pages 335-351

  Kenny, Louise ^a   Baker, Philip N ^b   Cunningham, F Gary ^c  

^a Irish Centre for Fetal and Neonatal Translational Research   (Ireland)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882467878     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374213-1.00018-5     Document Type: Chapter

References (155)

1. L. Chesley (1978) Hypertensive Disorders in Pregnancy. New York: Appleton-Century-Crofts
2. J.A. Pritchard, F.G. Cunningham and R.A. Mason (1976) Coagulation changes in eclampsia: their frequency and pathogenesis. Am J Obstet Gynecol 124 855-864.
3. H.L. Sheehan and J.B. Lynch (Eds) (1973) Cerebral Lesions. Pathology of Toxaemia of Pregnancy Baltimore: Williams & Wilkins
4. L. Weinstein (1982) Syndrome of hemolysis, elevated liver enzymes and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142 159-160.
5. L. Weinstein (1985) Preeclampsia-eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia. Obstet Gynecol 66 657-660.
6. G. Bizzozero (1985) Discovery of the platelet. M. Wintrole (Eds) Haematology, the Blossoming of a Science Philadelphia: Lea and Febiger 28-31.
7. J. White (2006) Platelet Structure. A. Michelson (Eds) Platelets San Diego: Academic Press 45-74.
8. C.W. Redman, J. Bonnar and L. Beilin (1978) Early platelet consumption in pre-eclampsia. Br Med J 1 467-469.
9. R.A. Fay, D.R. Bromham, J.A. Brooks and V.J. Gebski (1985) Platelets and uric acid in the prediction of preeclampsia. Am J Obstet Gynecol 152 1038-1039.
10. T.M. Stubbs, J. Lazarchick, J.P. Van Dorsten, J. Cox and C.B. Loadholt (1986) Evidence of accelerated platelet production and consumption in nonthrombocytopenic preeclampsia. Am J Obstet Gynecol 155 263-265.
11. Y. Ahmed, B. van Iddekinge, C. Paul, H.F. Sullivan and M.G. Elder (1993) Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia. BJOG 100 216-220.
12. S. Howarth, L.R. Marshall, A.L. Barr, S. Evans, M. Pontre and N. Ryan (1999) Platelet indices during normal pregnancy and pre-eclampsia. BJOG 56 20-22.
13. P. Hupuczi, B. Nagy, I. Sziller, B. Rigo, E. Hruby and Z. Papp (2007) Characteristic laboratory changes in pregnancies complicated by HELLP syndrome. Hypertens Pregnancy 26 389-401.
14. L. Heilmann, W. Rath and K. Pollow (2007) Hemostatic abnormalities in patients with severe preeclampsia. Clin Appl Thromb Hemost 13 285-291.
15. J.A. Pritchard, F.G. Cunningham, S.A. Pritchard and R.A. Mason (1987) How often does maternal preeclampsia-eclampsia incite thrombocytopenia in the fetus? Obstet Gynecol 69 292-295.
16. M.A. Brown and M.L. Buddle (1996) Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features. Med J Aust 165 360-365.
17. L. Leduc, J.M. Wheeler, B. Kirshon, P. Mitchell and D.B. Cotton (1992) Coagulation profile in severe preeclampsia. Obstet Gynecol. 79 14-18.
18. W.M. Barron, P. Heckerling, J.U. Hibbard and S. Fisher (1999) Reducing unnecessary coagulation testing in hypertensive disorders of pregnancy. Obstet Gynecol. 94 364-370.
19. J.M. Paulus (1975) Platelet size in man. Blood 46 321-336.
20. F. Pekonen, V. Rasi, M. Ammala, L. Viinikka and O. Ylikorkala (1986) Platelet function and coagulation in normal and preeclamptic pregnancy. Thromb Res 43 553-560.
21. I. Rakoczi, F. Tallian, S. Bagdany and I. Gati (1979) Platelet life-span in normal pregnancy and pre-eclampsia as determined by a non-radioisotope technique. Thromb Res 15 553-556.
22. T.C. Inglis, J. Stuart, A.J. George and A.J. Davies (1982) Haemostatic and rheological changes in normal pregnancy and pre-eclampsia. Br J Haematol 50 461-465.
23. J.T. Douglas, M. Shah, G.D. Lowe, J.J. Belch, C.D. Forbes and C.R. Prentice (1982) Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension. Thromb Haemost 47 54-55.
24. M. Hayashi, T. Inoue, K. Hoshimoto, H. Negishi, T. Ohkura and N. Inaba (2002) Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia. Eur J Haematol 69 297-302.
25. V.C. Ballegeer, B. Spitz, L.A. De Baene, A.F. Van Assche, M. Hidajat and A.M. Criel (1992) Platelet activation and vascular damage in gestational hypertension. Am J Obstet Gynecol 166 629-633.
26. S.L. Janes and A.H. Goodall (1994) Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci (Lond) 86 731-739.
27. M.L. Socol, C.P. Weiner, G. Louis, K. Rehnberg and E.C. Rossi (1985) Platelet activation in preeclampsia. Am J Obstet Gynecol 151 494-497.
28. R.F. Burrows, D.J. Hunter, M. Andrew and J.G. Kelton (1987) A prospective study investigating the mechanism of thrombocytopenia in preeclampsia. Obstet Gynecol 70 334-338.
29. P. Samuels, E.K. Main, A. Tomaski, M.T. Mennuti, S.G. Gabbe and D.B. Cines (1987) Abnormalities in platelet antiglobulin tests in preeclamptic mothers and their neonates. Am J Obstet Gynecol 157 109-113.
30. C.M. Middelkoop, G.A. Dekker, A.A. Kraayenbrink and C. Popp-Snijders (1993) Platelet-poor plasma serotonin in normal and preeclamptic pregnancy. Clin Chem 39 1675-1678.
31. A. Konijnenberg, E.W. Stokkers, J.A. van der Post, M.C. Schaap, K. Boer, O.P. Bleker and A. Sturk (1997) Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol 176 461-469.
32. Fitzgerald DJ, Mayo G, Catella F, Entman SS, FitzGerald GA. Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets. Am J Obstet Gynecol 157, 325-30.
33. D.J. Fitzgerald, W. Rocki, R. Murray, G. Mayo and G.A. FitzGerald (1990) Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet 335 751-754.
34. C. Van Geet, J. Arnout, E. Eggermont and J. Vermylen (1990) Urinary thromboxane B2 and 2,3-dinor-thromboxane B2 in the neonate born at full-term age. Eicosanoids 3 39-43.
35. G.G. Garzetti, A.L. Tranquilli, A.M. Cugini, L. Mazzanti, N. Cester and C. Romanini (1993) Altered lipid composition, increased lipid peroxidation, and altered fluidity of the membrane as evidence of platelet damage in preeclampsia. Obstet Gynecol 81 337-340.
36. P.N. Baker, F. Broughton Pipkin and E.M. Symonds (1992) Comparative study of platelet angiotensin II binding and the angiotensin II sensitivity test as predictors of pregnancy-induced hypertension. Clin Sci (Lond) 83 89-95.
37. L. Poulio, J.C. Forest, J.M. Moutquin, N. Coulombe and J. Masse (1998) Platelet angiotensin II binding sites and early detection of preeclampsia. Obstet Gynecol 91 591-595.
38. N. Maki, R.R. Magness, S. Miyaura, N.F. Gant and J.M. Johnston (1993) Platelet-activating factor-acetylhydrolase activity in normotensive and hypertensive pregnancies. Am J Obstet Gynecol 168 50-54.
39. E.H. Horn, J. Cooper, E. Hardy, S. Heptinstall and P.C. Rubin (1991) A cross-sectional study of platelet cyclic AMP in healthy and hypertensive pregnant women. Clin Sci (Lond). 80 549-558.
40. P.W. Howie (1997) The haemostatic mechanisms in pre-eclampsia. Clin Obstet Gynaecol 4 595-611.
41. Y. Ahmed, M.H. Sullivan and M.G. Elder (1991) Detection of platelet desensitization in pregnancy-induced hypertension is dependent on the agonist used. Thromb Haemost 65 474-477.
42. E. Delacretaz, N. de Quay, B. Waeber, et al. (1995) Differential nitric oxide synthase activity in human platelets during normal pregnancy and pre-eclampsia. Clin Sci (Lond) 88 607-610.
43. F. Bussolino, C. Benedetto, M. Massobrio and G. Camussi (1980) Maternal vascular prostacyclin activity in pre-eclampsia. Lancet 2 702.
44. R.C. Briel, D.G. Kieback and T.H. Lippert (1984) Platelet sensitivity to a prostacyclin analogue in normal and pathological pregnancy. Prostaglandins Leukot Med 13 335-340.
45. C. Dadak, A. Kefalides and H. Sinzinger (1985) Prostacyclin-synthesis stimulating plasma factor and platelet sensitivity in preeclampsia. Biol Res Pregnancy Perinatol 6 65-69.
46. N. Liel, I. Nathan, T. Yermiyahu, Z. Zolotov, J.R. Lieberman, A. Dvilansky and P.V. Halushka (1993) Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with pregnancy induced hypertension. Thromb Res 70 205-210.
47. I.F. Charo, R.D. Feinman and T.C. Detwiler (1989) Interrelations of platelet aggregation and secretion. J Clin Invest 60 866-873.
48. S.M. Barr, K.R. Lees, L. Butters, A. O’Donnell and P.C. Rubin (1989) Platelet intracellular free calcium concentration in normotensive and hypertensive pregnancies in the human. Clin Sci (Lond) 76 67-71.
49. G.H. Rao, J.D. Peller and J.G. White (1985) Measurement of ionized calcium in blood platelets with a new generation calcium indicator. Biochem Biophys Res Commun 132 652-657.
50. P. Erne, E. Mittelholzer, E. Burgisser, R. Fluckiger and F.R. Buhler (1984) Measurement of receptor induced changes in intracellular free calcium in human platelets. J Recept Res 4 587-604.
51. M.D. Kilby, F. Broughton Pipkin, S. Cockbill, S. Heptinstall and E.M. Symonds (1990) A cross-sectional study of basal platelet intracellular free calcium concentration in normotensive and hypertensive primigravid pregnancies. Clin Sci (Lond) 78 75-80.
52. M.B. Zemel, P.C. Zemel, S. Berry, et al. (1990) Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women. N Eng J Med 323 434-438.
53. J.H. Cho, F. Nash, Z. Fekete, M. Kimura, J.P. Reeves and A. Aviv (1995) Increased calcium stores in platelets from African Americans. Hypertension 25 377-383.
54. P.M. Kyle, M.C. Jackson, D.C. Buckley, M. de Swiet and C.W. Redman (1995) Platelet intracellular free calcium response to arginine vasopressin is similar in preeclampsia and normal pregnancy. Am J Obstet Gynecol 172 654-660.
55. J.M. Roberts, V. Lewis, N. Mize, A. Tsuchiya and J. Starr (1986) Human platelet alpha-adrenergic receptors and responses during pregnancy: no change except that with differing hematocrit. Am J Obstet Gynecol 154 206-210.
56. K.A. Louden, F. Broughton Pipkin, S. Heptinstall, S.C. Fox, J.R. Mitchell and E.M. Symonds (1991) Platelet reactivity and serum thromboxane B2 production in whole blood in gestation hypertension and pre-eclampsia. Br J Obstet Gynaecol 98 1239-1244.
57. E.H. Horn, J.A. Cooper, E. Hardy, S. Heptinstall and P.C. Rubin (1995) Longitudinal studies of platelet cyclic AMP during healthy pregnancy and pregnancies at risk of pre-eclampsia. Clin Sci (Lond) 89 91-99.
58. B.T. Mellion, L.J. Ignarro, E.H. Ohlstein, E.G. Pontecorvo, A.L. Hyman and P.J. Kadowitz (1981) Evidence for the inhibitory role of guanosine 3′, 5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57 946-955.
59. E. Hardy, P.C. Rubin and E.H. Horn (1994) Effects of nitric oxide donors in vitro on the arachidonic acid-induced platelet release reaction and platelet cyclic GMP concentration in pre-eclampsia. Clin Sci (Lond) 86 195-202.
60. T.J. Moore and G.H. Williams (1982) Angiotensin II receptors on human platelets. Circ Res 51 314-320.
61. Y.A. Ding, D.E. MacIntyre, C.J. Kenyon and P.F. Semple (1982) Angiotensin II effects on platelet function. J Hypertens Suppl 3 S251-S253.
62. A. Poplawski (1970) The effect of angiotensin II on the platelet aggregation induced by adenosine diphosphate, epinephrine and thrombin. Experientia 26 86.
63. H. Haller, T. Oeney, U. Hauck, A. Distler and T. Philipp (1989) Increased intracellular free calcium and sensitivity to angiotensin II in platelets of preeclamptic women. Am J Hypertens 2 238-243.
64. H.A. Cameron and N.G. Ardlie (1982) The facilitating effects of adrenaline on platelet aggregation. Prostaglandins Leukot Med 9 117-128.
65. P.N. Baker, F. Broughton Pipkin and E.M. Symonds (1990) Platelet angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in human pregnancy. Clin Sci (Lond) 79 403-408.
66. P.N. Baker, F. Broughton Pipkin and E.M. Symonds (1991) Platelet angiotensin II binding sites in normotensive and hypertensive women. Br J Obstet Gynaecol 98 436-440.
67. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 52: 2682-89.
68. Fletcher AP, Alkjaersig NK, Burstein R. The influence of pregnancy upon blood coagulation and plasma fibrinolytic enzyme function. Am J Obstet Gynecol 134: 743-51.
69. M. Maki (1983) Coagulation, fibrinolysis, platelet and kinin-forming systems during toxemia of pregnancy. Biol Res Pregnancy Perinatol 4 152-154.
70. Y. Stirling, L. Woolf, W.R. North, M.J. Seghatchian and T.W. Meade (1984) Haemostasis in normal pregnancy. Thromb Haemost 52 176-182.
71. C.D. Lox, M.M. Dorsett and R.M. Hampton (1983) Observations on clotting activity during pre-eclampsia. Clin Exp Hypertens 2 179-190.
72. N.D. Vaziri, J. Toohey, D. Powers, et al. (1986) Activation of intrinsic coagulation pathway in pre-eclampsia. Am J Med 80 103-107.
73. A. Fournie, M. Monrozies, G. Pointonnier, B. Boneu and R. Bierme (1981) Factor VIII complex in normal pregnancy, pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 88 250-254.
74. C.A. Thornton and J. Bonnar (1977) Factor VIII-related antigen and factor VIII coagulant activity in normal and pre-eclamptic pregnancy. Br J Obstet Gynaecol 84 919-923.
75. C.W. Redman, K.W. Denson, L.J. Beilin, F.G. Bolton and G.M. Stirrat (1977) Factor-VIII consumption in pre-eclampsia. Lancet 2 1249-1252.
76. M.C. Scholtes, G. Gerretsen and H.L. Haak (1983) The factor VIII ratio in normal and pathological pregnancies. Eur J Obstet Gynecol Reprod Biol 16 89-98.
77. P.W. Howie, C.R. Prentice and G.P. McNicol (1971) Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency. J Obstet Gynaecol Br Commonw 78 992-1003.
78. H.C.S. Wallenburg (1986) Changes in the coagulation system and platelets in pregnancy-induced hypertension and pre-eclampsia. F. Sharp, E.M. Symonds (Eds) Hypertension in Pregnancy. Proceedings of the 16th RCOG Study Group New York: Perinatology Press 227-248.
79. L. Wallmo, K. Karlsson and A.C. Teger-Nilsson (1984) Fibrinopeptide A and intravascular coagulation in normotensive and hypertensive pregnancy and parturition. Acta Obstet Gynecol Scand 63 637-640.
80. Z. Borok, J. Weitz, J. Owen, M. Auerback and H.L. Nossel (1984) Fibrinogen proteolysis and platelet alpha-granule release in preeclampsia/eclampsia. Blood 63 525-531.
81. W.H. Seegers (1978) Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture. Am J Clin Pathol 69 299-359.
82. G.H. Weenink, P.E. Treffers, L.H. Kahle and J.W. ten Cate (1982) Antithrombin III in normal pregnancy. Thromb Res 26 281-287.
83. C.P. Weiner and J. Brandt (1982) Plasma antithrombin III activity: an aid in the diagnosis of preeclampsia-eclampsia. Am J Obstet Gynecol 142 275-281.
84. G.H. Weenik, J.J. Borm, J.W. ten Cate and P.E. Treffers (1983) Antithrombin III levels in normotensive and hypertensive pregnancy. Gynecol Obstet Invest 16 230-242.
85. A.A. Saleh, S.F. Bottoms, R.A. Welch, A.M. Ali, F.G. Mariona and E.F. Mammen (1987) Preeclampsia, delivery, and the hemostatic system. Am J Obstet Gynecol 157 331-336.
86. K.H. Yin, S.C. Koh, P. Malcus, S. SvenMontan, A. Biswas, S. Arulkumaran and S.S. Ratnam (1998) Preeclampsia: haemostatic status and the short-term effects of methyldopa and isradipine therapy. J Obstet Gynaecol Res 24 231-238.
87. R. Schjetlein, G. Haugen and F. Wisloff (1997) Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstet Gynecol Scand 76 547-646.
88. D. Paternoster, A. Stella, P. Simioni, S. Trovo, P. Plebani and A. Girolami (1994) Clotting inhibitors and fibronectin as potential markers in preeclampsia. Int J Gynaecol Obstet 47 215-221.
89. H. Shinyama, T. Akira, T. Uchida, K. Hirahara, M. Watanabe and Y. Kagitani (1996) Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia. J Cardiovasc Pharmacol 27 702-711.
90. D.M. Paternoster, S. Fantinato, F. Manganelli, M. Milani, U. Nicolini and A. Girolami (2004) Efficacy of AT in pre-eclampsia: a case-control prospective trial. Thromb Haemost 91 283-289.
91. H. Sameshima, Y. Kodama, T. Ikenoue and Y. Kajiwara (2008) Antithrombin improves fetal condition in women with severe pre-eclampsia before 32 weeks of gestation; a randomized, double-blind, placebo-controlled trial. J Obstet Gynaecol Res. 34 34-39.
92. G. Larciprete, S. Gioia, P.A. Angelucci, et al. (2007) Single inherited thrombophilias and adverse pregnancy outcomes. J Obstet Gynaecol Res. 33 423-430.
93. G. Mello, E. Parretti, L. Marozio, et al. (2005) Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 46 1270-1274.
94. J.A. Fernandez, A. Estelles, J. Gilabert, F. Espana and J. Aznar (1989) Functional and immunologic protein S in normal pregnant women and in full-term newborns. Thromb Haemost 61 474-478.
95. G.A. Dekker, J.I. de Vries, P.M. Doelitzsch, P.C. Huijgens, B.M. von Blomberg, C. Jakobs and H.P. van Geijn (1995) Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 173 1042-1048.
96. Z. Alfirevic, D. Roberts and V. Martlew (2002) How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 101 6-14.
97. L. Robertson, O. Wu, P. Langhorne, et al. (2006) Thrombophilia in pregnancy: a systematic review. Br J Haematol 132 171-196.
98. J.T. Brandt (1985) Current concepts of coagulation. Clin Obstet Gynecol 28 3-14.
99. P.C. Comp, R.M. Jacocks, G.L. Ferrell and C.T. Esmon (1982) Activation of protein C in vivo. J Clin Invest 70 127-134.
100. R. Gonzalez, I. Alberca and V. Vicente (1985) Protein C levels in late pregnancy, postpartum and in women on oral contraceptives. Thromb Res 39 637-640.
101. C.P. Weiner and J. Brandt (1980) Plasma antithrombin III activity in normal pregnancy. Obstet Gynecol 56 601-603.
102. K. de Boer, J.W. ten Cate, A. Sturk, J.J. Borm and P.E. Treffers (1989) Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 160 95-100.
103. B. Dahlback, M. Carlsson and P.J. Svensson (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 90 1004-1008.
104. R.M. Bertina, B.P. Koeleman, T. Koster, et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 64-67.
105. V. Spina, V. Aleandri and F. Morini (2000) The impact of the factor V Leiden mutation on pregnancy. Hum Reprod Update 6 301-306.
106. V. De Stefano, P. Chiusolo, K. Paciaroni and G. Leone (1998) Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost 24 367-379.
107. R. Rai, A. Shlebak, H. Cohen, et al. (2001) Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 16 961-965.
108. P.G. Lindqvist, P. Svensson and B. Dahlback (2006) Activated protein C resistance – in the absence of factor V Leiden – and pregnancy. J Thromb Haemost 4 361-366.
109. J.R. Higgins, T. Kaiser, E.K. Moses, R. North and S.P. Brennecke (2000) Prothrombin G20210A mutation: is it associated with pre-eclampsia? Gynecol Obstet Invest 50 254-257.
110. M.J. Kupferminc, H. Peri, E. Zwang, Y. Yaron, I. Wolman and A. Eldor (2000) High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand 79 963-967.
111. J.C. Livingston, V. Park, J.R. Barton, et al. (2001) Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels. Am J Obstet Gynecol 184 1273-1277.
112. S. Muetze, B. Leeners, J.R. Ortlepp, et al. (2008) Maternal factor V Leiden mutation is associated with HELLP syndrome in Caucasian women. Acta Obstet Gynecol Scand 87 635-642.
113. M.J. Kupferminc, A. Eldor, N. Steinman, et al. (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Eng J Med 340 9-13.
114. H.P. McNeil, C.N. Chesterman and S.A. Krilis (1991) Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49 193-280.
115. N.S. Pattison, L.W. Chamley, E.J. McKay, G.C. Liggins and W.S. Butler (1993) Antiphospholipid antibodies in pregnancy. Br J Obstet Gynaecol 100 909-913.
116. M. Yasuda, K. Takakuwa, A. Tokunaga and K. Tanaka (1995) Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 86 555-559.
117. R. Rai, H. Cohen, M. Dave and L. Regan (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314 253-257.
118. CLASP (1994) a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 343 619-629.
119. J.J. Kalk, A.J. Huisjes, C.J. de Groot, et al. (2004) Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment? Neth J Med 62 83-87.
120. G. Mello, E. Parretti, C. Fatini, et al. (2005) Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 45 86-91.
121. F. Sergio, D. Maria Clara, F. Gabriella, S. Giorgia, C. Sara De, P. Giancarlo and C. Alessandro (2006) Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. Hypertens Pregnancy 25 115-127.
122. J. Bonnar, L. Daly and B.L. Sheppard (1990) Changes in the fibrinolytic system during pregnancy. Semin Thromb Hemost 16 221-229.
123. S.C. Koh, C. Anandakumar, S. Montan and S.S. Ratnam (1993) Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in preeclampsia. Gynecol Obstet Invest 35 214-221.
124. C.H. Ho and Z.L. Yang (1992) The predictive value of the hemostasis parameters in the development of preeclampsia. Thromb Haemost 67 214-218.
125. J. Thorburn, M.M. Drummond, K.A. Whigham, G.D. Lowe, C.D. Forbes, C.R. Prentice and C.R. Whitefield (1982) Blood viscosity and haemostatic factors in late pregnancy, pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 89 117-122.
126. J.A. Spencer, M.J. Smith, S.A. Cederholm-Williams and A.R. Wilkinson (1983) Influence of pre-eclampsia on concentrations of haemostatic factors in mothers and infants. Arch Dis Child 58 739-741.
127. S.A. Friedman, E. Schiff, J.J. Emeis, G.A. Dekker and B.M. Sibai (1995) Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol 172 202-203.
128. A. Estelles, J. Gilabert, M. Keeton, et al. (1994) Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood 84 143-150.
129. J. Gilabert, A. Estelles, J. Aznar, F. Espana, C. Andres, T. Santos and J. Valles (1990) Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia. Thromb Haemost 63 361-366.
130. K. de Boer, I. Lecander, J.W. ten Cate, J.J. Borm and P.E. Treffers (1988) Placental-type plasminogen activator inhibitor in preeclampsia. Am J Obstet Gynecol 158 518-522.
131. A. Nakashima, T. Kobayashi and T. Terao (1996) Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors. Gynecol Obstet Invest 42 95-101.
132. A. Estelles, J. Gilabert, F. Espana, J. Aznar and M. Galbis (1991) Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am J Obstet Gynecol 165 138-142.
133. A. Kanfer, J.F. Bruch, G. Nguyen, et al. (1996) Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia. Lab Invest 74 253-258.
134. B. Gibson, D. Hunter, P.B. Neame and J.G. Kelton (1982) Thrombocytopenia in preeclampsia and eclampsia. Semin Thromb Hemost 8 234-247.
135. Y.B. Gordon, S.M. Ratky, L.R. Baker, A.T. Letchworth, P.C. Leighton and T. Chard (1976) Circulating levels of fibrin/fibrinogen degradation fragment E measured by radioimmunoassay in pre-eclampsia. Br J Obstet Gynaecol 83 287-291.
136. P.J. Gaffney, L.J. Creighton, M. Callus and R. Thorpe (1988) Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II. Evaluation in a variety of clinical conditions. Br J Haematol 68 91-96.
137. K.F. Trofatter Jr., M.L. Howell, C.S. Greenberg and M.L. Hage (1989) Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia. Obstet Gynecol 73 435-440.
138. C.J. Glueck, M.J. Kupferminc, R.N. Fontaine, P. Wang, B.B. Weksler and A. Eldor (2001) Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 97 44-48.
139. E.W. Page (1972) On the pathogenesis of pre-eclampsia and eclampsia. J Obstet Gynaecol Br Commonw 79 883-894.
140. K.J. Manas, J.D. Welsh, R.A. Rankin and D.D. Miller (1985) Hepatic hemorrhage without rupture in preeclampsia. N Eng J Med 312 424-426.
141. S.A. Rosen, S.H. Merchant, T.J. Vanderjagt and K.P. Crookston (2003) Spontaneous subcapsular liver hematoma associated with pregnancy. Arch Pathol Lab 127 1639-1640.
142. V.K. Shrivastava, D. Imagawa and D.A. Wing (2006) Argon beam coagulator for treatment of hepatic rupture with hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome. Obstet Gynecol 107 525-526.
143. S.H. Merchant, P. Mathew, T.J. Vanderjagt, T.R. Howdieshell and K.P. Crookston (2004) Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Obstet Gynecol 103 1055-1058.
144. B.K. Rinehart, D.A. Terrone, E.F. Magann, R.W. Martin, W.L. May and J.N. Martin (1999) Preeclampsia-associated hepatic hemorrhage and rupture: mode of management related to maternal and perinatal outcome. Obstet Gynecol Surv 54 196-202.
145. S.K. Hunter, M. Martin, J.A. Benda and F.J. Zlatnik (1995) Liver transplant after massive spontaneous hepatic rupture in pregnancy complicated by preeclampsia. Obstet Gynecol 85 819-822.
146. C. Wicke, P.L. Pereira, E. Neeser, I. Flesch, E.A. Rodegerdts and H.D. Becker (2004) Subcapsular liver hematoma in HELLP syndrome: evaluation of diagnostic and therapeutic options – a unicenter study. Am J Obstet Gynecol 190 106-112.
147. B.M. Sibai, M.K. Ramadan, I. Usta, M. Salama, B.M. Mercer and S.A. Friedman (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169 1000-1006.
148. B.M. Sibai and J.R. Barton (2007) Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol 196 514e1–e9
149. W. Ganzevoort, A. Rep, G.J. Bonsel, W.P.F. Fetter, L. Sonderen, J.I.P. Vries and H. Wolf (2005) A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset preeclampsia. BJOG 112 1358-1368.
150. B. Haddad, J.R. Barton, J.C. Livingston, R. Chahine and B.M. Sibai (2000) Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 183 444-448.
151. J.E. Fonseca, F. Méndez, C. Cataño and F. Arias (2005) Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: Double blind placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 193 1591-1598.
152. J.N. Martin Jr., B.D. Thigpen, C.H. Rose, et al. (2003) Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol 189 830.
153. C.M. Isler, P.S. Barrilleaux, E.F. Magann, J.D. Bass and J.N. Martin (2001) A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 184 1332-1337.
154. A.C. Vidaeff and E.R. Yeomans (2007) Corticosteroids for the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP): what evidence? Minerva Ginecol 59 183-190.
155. L. Katz, M.M.R. DeAmorim, J.N. Figueiroa and J.L.P. de Silva (2008) Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 198 283e1–e8